http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-42290-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5deddb47ccaab1d4da2aacc344dd8717 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-44 |
| filingDate | 1975-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-42290-L |
| titleOfInvention | 4-aminoquinoline derivatives |
| abstract | 1474296 4-Aminoquinoline derivatives JOHN WYETH & BRO Ltd 23 Jan 1976 [23 Jan 1975] 2924/75 Addition to 1416872 Heading C2C The invention comprises compounds of formula and their acid addition salts, wherein X is halogen or CF 3 ; Z is H, halogen, CF 3 , OH, NO 2 , R, RO, RNH or (R) 2 N, where R is C 1-6 alkyl; R<SP>1</SP> is H or R; and R<SP>2</SP> is RNH-A or (R) 2 N-A (A being C 1-6 alkylene), or piperidyl (optionally 1-substituted by aryl-A- or R); or NR<SP>1</SP>R<SP>2</SP> is RNH- or (R) 2 N- substituted piperidine. In examples, these compounds are prepared by reacting the corresponding acid chloride with HNH<SP>1</SP>R<SP>2</SP>. Therapeutic compositions having antiinflammatory activity, and in certain eases antihypertensive or blood platelet aggregation inhibiting activity, comprise compounds of the above formula, and may be administered (e.g.) orally or parenterally.n[GB1474296A] |
| priorityDate | 1975-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517 |
Total number of triples: 13.